Drug absorption through a cell monolayer: A theoretical work on a non-linear three-compartment model

European Journal of Pharmaceutical Sciences

Volumn 37, Issue 2, 2009, Pages 106-114

  Komin, Niko ^a   Toral, Raúl ^a  

^a INSTITUTO DE FÍSICA INTERDISCIPLINAR Y SISTEMAS COMPLEJOS IFISC CSIC UIB   (Spain)

Author keywords

Absorption kinetics; Efflux mechanisms; Michaelis Menten; Non linear absorption; Three compartment model

Indexed keywords

ANTIBIOTIC AGENT; CNV 97100; GLYCOPROTEIN P; UNCLASSIFIED DRUG;

ARTICLE; COMPARTMENT MODEL; CURVE FITTING; DRUG ABSORPTION; DRUG PENETRATION; HUMAN; HUMAN CELL; MONOLAYER CULTURE; NONLINEAR SYSTEM; PARAMETER; PRIORITY JOURNAL; THREE COMPARTMENT MODEL;

ABSORPTION; CACO-2 CELLS; HUMANS; MODELS, THEORETICAL; PHARMACOKINETICS;

EID: 62649119637     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.01.005     Document Type: Article

References (30)

1. Acharya P., Thuy T.T., Polli J.W., Ayrton A., Ellens H., and Bentz J. P-glycoprotein (p-gp) expressed in a confluent monolayer of hmdr1-mdckii cells has more than one efflux pathway with cooperative binding sites. Biochemistry 45 (2006) 15505-15519
2. Artursson P., and Borchardt R.T. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharmaceutical Research 14 12 (1997) 1655-1658
3. Artursson P., Palm K., and Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery Reviews 46 (2001) 27-43
4. Balimane P.V., Chong S., and Morrison R.A. Current methodologies used for evaluation of intestinal permeability and absorption. Journal of Pharmacological and Toxicological Methods 44 (2000) 301-312
5. Balimane P.V., Patel K., Anthony M., and Chong S. Utility of 96-well caco-2 cell system for increased throughput of p-gp screening in drug discovery. European Journal of Pharmaceutics and Biopharmaceutics 58 (2004) 99-105
6. Bermejo M., Avdeef A., Ruiz A., Nalda R., Ruell J.A., Tsinman O., González I., Fernández C., Sánchez G., Garrigues T.M., and Merino V. Pampa-a drug absorption in vitro model: 7. comparing rat in situ, caco-2, and pampa permeability of fluoroquinolones. European Journal of Pharmaceutical Sciences 21 4 (2004) 429-441
7. Bermejo M., Merino V., Garrigues T.M., Delfina J.M.P., Mulet A., Vizet P., Trouiller G., and Mercier C. Validation of a biophysical drug absorption model by the patqsar system. Journal of Pharmaceutical Sciences 88 4 (1999) 398-405
8. Boyce W.E., and DiPrima R.C. Elementary Differential Equations and Boundary Value Problems (2001), John Wiley & Sons Inc.
9. Eddershaw P.J., Beresford A.P., and Bayliss M.K. Adme/pk as part of a rational approach to drug discovery. Drug Discovery Today 5 9 (September 2000)
10. Faassen F., Vogel G., Spanings H., and Vromans H. Caco-2 permeability, p-glycoprotein transport ratios and brain penetration of heterocyclic drugs. International Journal of Pharmaceutics 263 (2003) 113-122
11. Fick A. Ueber diffusion. Annalen der Physik 170 (1855) 59-86
12. Gonzalez-Alvarez I., Fernandez-Teruel C., Garrigues T., Casabo V., Ruiz-García A., and Bermejo M. Kinetic modelling of passive transport and active efflux of a fluoroquinolone across caco-2 cells using a compartmental approach in nonmem. Xenobiotica (December 2005)
13. Hennessy M., and Spiers J. A primer on the mechanics of p-glycoprotein the multidrug transporter. Pharmacological Research 55 (2007) 1-15
14. Hunter J., and Hirst B.H. Intestinal secretion of drugs. the role of p-glycoprotein and related drug efflux systems in limiting oral drug absorption. Advanced Drug Delivery Reviews 25 (1997) 129-157
15. Irvine J.D., Takashi L., Lockhart K., Cheong J., Tolan J.W., Selick H.E., and Grove J.R. Mdck (madin-darby canine kidney) cells: a tool for membrane permeability screening. Journal of Pharmaceutical Sciences 88 1 (1999) 28-33
16. m value of efflux pump substrates. Drug Metabolism amd Disposition 35 9 (2007) 1574-1579
17. Kramer W.G., Lewis R.P., Tyson C.C., Forester W.F., Visconti J.F., Wanke L.A., Boxenbaum H.G., and Reuning Jr. R.H. Pharmacokinetics of digoxin: Comparison of a two- and a three-compartment model in man. Journal of Pharmacokinetics and Biopharmaceutics 2 4 (1974) 299-312
18. Lentz K.A., Polli J.W., Wring S.A., Humphreys J.E., and Polli J.E. Influence of passive permeability on apparent p-glycoprotein kinetics. Pharmaceutical Research 17 12 (2000)
19. Michaelis L., and Menten M. Die kinetik der invertinwirkung. Biochemische Zeitschrift (1913) 333-369
20. Mizuarai S., Aozasa N., and Hidehito K. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter abcg2. International Journal of Cancer 109 (2004) 238-246
21. Raviv Y., Pollard H., Bruggemann E., Pastan I., and Gottesman M. Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. Journal of Biological Chemistry 7 (1990) 3975-3980
22. Ruiz-Garcia A., Lin H., Plá-Delfina J.M., and Hu M. Kinetic characterization of secretory transport of a new ciprofloxacin derivative (cnv97100) across caco-2 cell monolayers. Journal of Pharmaceutical Sciences 91 12 (2002) 2511-2519
23. Sharma K.G., Mason D.L., Liu G., Rea P.A., Bachhawat A.K., and Michaelis S. Localization, regulation, and substrate transport properties of bpt1p, a saccharomyces cerevisiae mrp-type abc transporter. Eukaryotic Cell 1 3 (2002) 391-400
24. Skinner S.M., Clark R.E., Baker N., and Shipley R.A. Complete solution of the three-compartment model in steady state after single injection of radioactive tracer. American Journal of Physiology 196 (1959) 238-244
25. Troutman M.D., and Thakker D.R. Efflux ratio cannot assess p-glycoprotein-mediated attenuation of absorptive transport: Asymmetric effect of p-glycoprotein on absorptive and secretory transport across caco-2 cell monolayers. Pharmaceutical Research 20 8 (August 2003) 1200-1209
26. Troutman M.D., and Thakker D.R. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by p-glycoprotein in cell culture models of intestinal epithelium. Pharmaceutical Research 20 8 (August 2003) 1210-1224
27. Volk E.L., and Schneider E. Wild-type breast cancer resistance protein (bcrp/abcg2) is a methotrexate polyglutamate transporter. Cancer Research 63 (September 2003) 5538-5543
28. Yamashita S., Furubayashi T., Kataoka M., Sakane T., Sezaki H., and Tokuda H. Optimized conditions for prediction of intestinal drug permeability using caco-2 cells. European Journal of Pharmaceutical Sciences 10 (2000) 195-204
29. Yu L.X., and Amidon G.L. A compartmental absorption and transit model for estimating oral drug absorption. International Journal of Pharmaceutics 186 (1999) 119-125
30. Zhou H. Pharmacokinetic strategies in deciphering atypical drug absorption profiles. The Journal of Clinical Pharmacology 43 (2003) 211-227